The identification of early markers of myeloid differentiation can facilitate an understanding of how differentiation is arrested in leukemogenesis. Using murine bone marrow and the granulocyte-precursor cell line 32Dcl3, we show that message for the granulocyte colony-stimulating factor receptor (G-CSFR) is upregulated by G-CSF in an immediate early fashion that is specific to the differentiation path-ISRUPTION OF THE transition from proliferation to differentiation is postulated to be central to the pathogenesis of leukemia.' Evidence that this may occur by dominant suppression of genes in the differentiation pathway is accum~lating.~.~ Such a mechanism has been proposed to underlie leukemic transformation by V-ERB A4-7 and possibly by the PML-RARa fusion Elucidation of the degree to which such dominant suppression contributes to myeloid leukemogenesis has been hampered by the paucity of immediate early markers of myeloid commitment to differentiation. Such markers are most likely to uncover specific factors coordinating the unfolding of the differentiation program and to help define targets of leukemic dysregulation.
ISRUPTION OF THE transition from proliferation to
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Several in vitro models of myeloid differentiation have been used to study how differentiation can be blocked in leukemic cells. One such model, the murine granulocytic precursor cell line 32Dc13," is a nontumorigenic, diploid cell line that is dependent on interleukin-3 (IL-3) for proliferation. These cells can be induced to differentiate into mature neutrophils on replacement of IL-3 with granulocyte colony-stimulating factor (G-CSF). Coculture in IL-3 can delay the differentiation response to G-CSF in a dose-dependent fashion," suggesting an antagonism between proliferation and differentiation.
Transformed 32Dc13 cells have been used to identify elements of the proliferative pathway that oppose myeloid differentiation. The IL-3 dependence of 32Dc13 can be abrogated by activated oncogenes of the tyrosine kinase class, including v-abl, l 3 v-src, l4 and various constructs bearing the tyrosine kinase portion of epidermal growth factor receptor." In addition to providing a proliferative signal, v-ab1 has been shown to interfere with G-CSF-mediated differentiation. 13 The genes targeted by the differentiation blockade in these instances remain largely unknown.
A number of markers of the G-CSF differentiation pathway are known, such as the gradual appearance of chloroacetate esterase, myeloperoxidase, and lactofemn activity.12 Exposure of myeloid precursors to G-CSF results in an increase infosI6.l7 and mycl' transcripts and in IL-l-receptor e x p r e s~i o n . '~~~~ However, these genes have not been identified as immediate early markers specific to myeloid differentiation or as targets of suppression in leukemogenesis. One study also identified c-jun, jun-B, Tis-7, Tis-8, and Tis-I I as early genes upregulated by G-CSF, although it was unclear in this study whether IL-3 withdrawal or G-CSF addition led to the observed effects and whether the upregulation was specific to G-CSF-mediated differentiation.I6 In the present study, we report that upregulation of message for the murine G-CSF receptor (mG-CSFR) is an immediate early marker of the myeloid differentiation pathway. A survey ofleukemic cell lines established that the mG-CSFR gene message is aberrantly regulated in several murine leukemia models and is a target of suppression by the abl-oncogene product.
MATERIALS AND METHODS

Cytokines
Human native G-CSF was partially purified from the conditioned media of U87MG cells as described'; recombinant human G-CSF (Amgen, Thousand Oaks, CA) was used when indicated. Murine recombinant IL-3 (GIBCO BRL, Gaithersberg, MD) was used as noted; otherwise, WEHI-3B-conditioned media (CM) was used as a source of IL-3. WEHI-3B and U87MG supernatants were quantitated for IL-3 and G-CSF activity, respectively, as previously described.2'
Probes
The mG-CSFR probe was the EcoRl insert obtained from plasmid PTA-I generated by cloning our polymerase chain reaction (PCR)-generated fragment (below) into the TA cloning kit vector (Invitrogen, San Diego, CA). Nick-translated ~T A B 1 ,~~p r o v i d e d by Dr Steve Goff, was used as an Ablprobe. The 18s rRNA plasmid, obtained from Dr Christine Milcarek, has been described.23 The rat @-actin probe was obtained from Dr Roberto Giorda (University of Pittsburgh School of Medicine, Pittsburgh, PA).
Cell Lines 32Dc13 was passaged in Iscove's modified Dulbecco's medium (IMDM; GIBCO-BRL) supplemented with 10% WEHI-CM, peni-cillin (50 U/mL), streptomycin (50 U/mL), and 20% heat-inactivated fetal calf serum (FCS) and maintained in log-phase growth by splitting 1:20 every 5 days. NFS60 was maintained in IMDM with 1% heat-inactivated FCS, 10% WEHI-CM, penicillin, streptomycin, and 5 X mol/L P-mercaptoethanol. Temperature-sensitive dl-transformed 32Dc13 clones RKl and RK3 were a gift of Dr John Cleveland (St Judes Hospital, Memphis, TN) and were maintained similarly to the parent line except that WEHI-CM was omitted and cells were maintained at 32°C. The WEHI-3B D-and D+ sublines were provided by Dr Malcolm Moore (Memorial SloanKettering Cancer Center, New York, NY), were maintained in RPM1 supplemented with 10% heat-inactivated FCS, penicillin, and streptomycin, and were split at 1 : 100 every 5 days.
Generation o f v-ab1 Transformed 320 Cells
v-ab1 transformants of 32Dc13 were generated by coelectroporation of helper plasmid pNCA and p160 Abl plasmid P T A B I~~ into 1.5 X IO6 32Dc13 cells. Twenty-four hours after electroporation, cells were selected for IL-3 independence in IMDM with 20% FCS. A mass culture ofcells surviving after I2 days was cloned by limiting dilution; six clones were expanded in the absence of IL-3 for further studies, and transfected abl signals were verified on Southern blot.
Northern Blot Analysis
Total RNA was extracted from cell lines by solubilization in 4 mol/L guanidium isothiocyanate followed by centrifugation through a cesium chloride cushion.24 A total of 15 to 30 pg of total RNA was separated on agarose-formaldehyde gels,25 blotted onto Zetabind (AMF-Cuno, Meridan, CT), covalently bound by brief UV irradiation, and hybridized by established procedures26 to probes radiolabeled to 5 to IO X 10' cpm/Fg by random priming according to manufacturer's instructions (GIBCO-BRL). Blots were exposed to Kodak XAR-5 film (Eastman Kodak, Rochester, NY) with intensifying screens at -80°C. Exposure times varied from 3 to 6 days for mG-CSFR, I to 2 days for v-abl, and 4 to 18 hours for actin and 18s probes. Quantification was performed on a densitometer (model 620; Bio-Rad, Richmond, CA) in two dimensions.
PCR
Twenty-one-basepair amplimers were synthesized at the University of Pittsburgh DNA synthesis facility (Pittsburgh, PA) with the following sequences, 5' amplimer, TTCCTGGACAACGAAGGT-CCA and 3' amplimer, CAGGGTCTTCAAGATACAAGG, and used in PCR assays on genomic DNA (5 &reaction) or cDNA (1 pg/reaction) using Taq polymerase and temperature assignments of 94°C (melting), 55°C (annealing), and 72°C (extension) through 30 cycles. The 1.2-kb PCR product was cloned in both orientations into the plasmid pCR (TA cloning kit; Invitrogen) for storage and sequencing.
RESULTS
Generation o f a Murine G-CSFR Probe
The sequence of the cDNA for the mG-CSFR (isolated from the murine cell line NFS60) has been p~blished.~' We cloned a 1.2-kb carboxy-terminal fragment of the 32Dc13-cell G-CSFR gene using PCR techniques and 32Dc13-genomic DNA as a template. We amplified a single fragment extending from nucleotides (nt) 1460-27 10 that includes sequences encoding the cytoplasmic domain, the membranespanning portion, and one-third of the extracellular domain. This fragment lacked intervening intron sequences and probably represented a pseudogene; sequencing showed only 90% homology to the mG-CSFR cDNA,*' and Southern blot data were consistent with a two-gene G-CSFR family, one member of which lacks intervening sequences (R. Steinman, unpublished observation, February 199 I). This fragment hybridized to a message of 3.2 kb and has been used to clone the human G-CSFR cDNA from an HL60 cell library.28
Regulation of mG-CSFR mRNA in 320~13 and Bone Marrow Cells Enhuncement ofmG-CSFR mRNA expression by G-CSF.
We were curious as to whether activation of the mG-CSFR resulted in upregulation of its own message. We used the murine hematopoietic progenitor cell line 32Dc13 to assess whether mG-CSFR mRNA levels were altered by exposure to its ligand. Although this cell line is strictly dependent on IL-3 for long-term survival, G-CSF will support 32Dc13 growth through one to two replication cycles followed by granulocytic differentiation.12
After depriving 32Dc13 cells of IL-3 for 3 hours, we incubated them for varying durations of time in the presence of either native" or recombinant G-CSF. Because G-CSF initially transduces a signal along both proliferative and differentiative pathways, any observed G-CSF-induced effect could theoretically map to either branch. For this reason, we also monitored the effect of a proliferative control by adding IL-3 back to some samples. As shown in Fig 1 A , reexposure to IL-3 for 4 or 8 hours did not increase the level of mG-CSFR message; however, a marked increase in mG-CSFR message was apparent after 4 hours of exposure to G-CSF. The fact that IL-3 did not upregulate mG-CSFR message suggests that this increase was not a general marker of proliferation but instead was mapped to the G-CSF-mediated differentiation pathway. Marrow from C3H/HeJ mice also showed upregulation of mG-CSFR message after exposure to G-CSF (Fig 1 B) . The upregulation of mG-CSFR message in 32Dc13 was specific to G-CSF and did not occur on exposure of cells to agents noted to promote myeloid differentiation in other in vitro systems (but not in 32Dc13), such as granulocyte-macrophage-CSF (GM-CSF), 1,25-dihydroxyvitamin D3, 12-0-tetradecanoylphorbol-13-acetate (TPA), retinoic acid, or dimethyl sulfoxide (DMSO). In addition, the upregulation of mG-CSFR message in 32Dc13 cells incubated in G-CSF is not caused by IL-3 withdrawal (Fig 2) .
Regulation of'mG-CSFR mRNA expression. To establish whether G-CSF upregulated mG-CSFR message by prolonging its half-life, we conducted an actinomycin-D chase experiment on 32Dc13 cells using an actinomycin-D concentration of I O pg/mL. At this concentration of actinomycin D, 32Dc13 cells remained viable for more than 6 hours but did not synthesize RNA, as shown by inhibition of uridine incorporation (Fig 3D) . After resting 32Dc13 cells in IL-3-free media for 3 hours, we divided the cells into two aliquots; one aliquot was exposed to G-CSF, and another to medium alone. Four hours later, actinomycin D was added to each aliquot. Cells were removed from each aliquot at 0, hours, and then either exposed to G-CSF or reexposed to IL-3 for 4 or 8 hours. IL-3 (I) is added at 100 U/mL; G-CSF is supplied either as native (G) form at 30 U/mL or recombinant (r) form at 40 U/mL. A Northern blot of 20 pg total RNA is shown. mG-CSFR and actin probes and hybridization conditions are as in experimental procedures. (B) Bone marrow was harvested from C3He/J mice and immediately incubated in medium containing either 100 U/mL IL-3 or 30 U/mL G-CSF for the indicated times.
2,4, and 6 hours after actinomycin-D addition, and the level of mG-CSFR mRNA was determined by Northern blot. Later time points could not be observed because of diminishing cell viability in the absence of IL-3. It was apparent that the mG-CSFR message has a long half-life in unstimulated cells, showing minimal decrease in message level over 121 6 hours in the presence of actinomycin D (Fig 3A) . No alteration of mG-CSFR half-life was apparent after G-CSF exposure (Fig 3B) . These results indicated that augmentation of mG-CSFR message by G-CSF most likely was not caused by mG-CSFR mRNA stabilization.
To determine if ongoing transcription is required for upregulation of mG-CSFR mRNA by G-CSF, actinomycin D was added together with G-CSF to resting 32Dc13 cells for 6 hours (Fig 3C) . Actinomycin D blocked the increase in the steady-state mG-CSFR mRNA level. suggesting that the effect of G-CSF on steady-state levels of mG-CSFR mRNA may be mediated, at least in part, by enhanced mG-CSFR gene transcription.
Additional studies were conducted to establish whether mG-CSFR might be an immediate early gene in the G-CSF genetic program. Such immediate early genes do not require new protein synthesis to be induced. To examine whether new protein synthesis was required for G-CSF to upregulate mG-CSFR message, 32Dc13 cells were washed free of IL-3, rested for 3 hours in factor-free medium and then exposed for 8 hours to medium alone. G-CSF alone. cycloheximide (5 pg/mL) alone. or both G-CSF and cycloheximide. The cycloheximide concentration used resulted in 95% maximum achievable inhibition of trichloroacetate-precipitable %-methionine incorporation in 32Dc13 (data not shown). To discriminate between these possibilities, we compared mG-CSFR message in the presence of actinomycin, cycloheximide. or both. We found that actinomycin D abolished mG-CSFR upregulation by cycloheximide, supporting the conclusion that cycloheximide upregulated mG-CSFR mRNA expression by releasing the gene from a transcriptional block (Fig 4) . 0.wrcyyrlation qfmG-CSFR A4ma.w in 320~13 hjs IL-3 and v-ab1 mG-CSFR message in the presencc of IL-3. IL-3 has been reported to oppose G-CSF-mediated differentiation of 32Dc13 cells.'2 Because mG-CSFR upregulation appeared to be a specific early marker of the differentiation pathway. we were eager to examine whether IL-3 suppressed mG-CSFR upregulation by G-CSF. Our observations of the kinetics of mG-CSFR upregulation suggested such an antagonism. We had noted that the longer 32Dc13 cells were prein- cubated in IL-3-free medium, the earlier we could discern upregulation of mG-CSFR by G-CSF. For instance. G-CSF increased mG-CSFR message within I hour in cells rested overnight in IL-3-free medium: a similar degree of induction required 4 hours ifcells had been in IL-3-free medium for only 4 hours before G-CSF addition (data not shown). Figure 5 shows that coculture of 32Dc13 cells in the presence of 200 U/mL of IL-3 negated the upregulation of mG-CSFR by G-CSF. At 24 hours. cells exposed to G-CSF alone have increased mG-CSFR message 15-fold: however, message remains at basal levels in cells exposed to both G-CSF and IL-3 ( Fig 5B) . We examined whether IL-3 destabilized the mG-CSFR message in 32Dc13 cells. This has been reported for macrophage (M)-CSF receptor message, which is posttranscriptionally suppressed by both GM-CSF and IL-3." In contrast to M-CSFR mRNA, we found that mG-CSFR message stability was not decreased by IL-3 (Fig X ) . Posttranscriptional mechanisms were, therefore, unlikely to account for the ability of IL-3 to abrogate G-CSF-induced upregulation of mG-CSFR mRNA.
Altered regdation (?f' mG-CSFR message in abltransfected 320~13. v-ah/ has been noted to confer IL-3 independence on 32Dc13 cells and block their differentiation into granulocytes in response to G-CSF, arresting their transition from myeloblasts to promyelocytes." To determine whether the pattern of mG-CSFR mRNA regulation observed in the normal differentiation pathway is altered by vabl, we generated six independent v-ah/ transformants of 32Dc13. In addition. we studied temperature sensitive (ts)-ah/-transformed 32Dc13 clones RKI and RK3.3'*3' South- We examined several other leukemic cell lines for evidence of dysregulation of mG-CSFR message. These cell lines were chosen because they have been arrested at distinct and different stages of myeloid differentiation and have been characterized as aberrant producers of oncogenic transcription factors ( Table l) . The myeloid leukemic cell line NFS60 has an undifferentiated or early myeloid morphology. It constitutively produces c -~n v h~~ and c -e~i . '~ Despite the presence of these factors, mG-CSFR regulation in these cells is no different than in untransformed 32Dc13, displaying upregulation of message with G-CSF and superinduction with cycloheximide (Fig 8) . The WEHI-3B D' subline is arrested at the early promyelocytic or promonocytic stage but differentiates in response to G-CSF. 35 .36 It showed a high level of constitutive production of mG-CSFR, which was not augmented even after 24 hours of exposure to G-CSF (Fig 8) . We also examined mG-CSFR regulation in the ern blot analysis disclosed no gross rearrangements and an equal copy number of the mG-CSFR gene in all cell lines (data not shown). Northern blot analysis indicated that, compared with resting or IL-3-exposed 32Dc13 cells, basal expression of mG-CSFR mRNA was suppressed in all six vah1 transformants and in two ts-ah1 32Dc13 clones at the permissive temperature (Fig 6) . Furthermore, neither G-CSF nor cycloheximide, added alone or in combination, could upregulate mG-CSFR message in v-ahl-transformed clones (Fig 7) . Because of the possibility that mG-CSFR was unexpressed and uninducible in our v-abl-transformed cell lines as a result of selective transformation of underexpressing clones, we assayed mG-CSFR message in ts-ah1 clones. Whereas ts-ab1 clones showed basal expression and upregulation of mG-CSFR mRNA at the nonpermissive temperature (39"C), no message could be detected in the presence of G-CSF at the permissive temperature (32'C; Fig 7) . Repression of mG-CSFR message in ts-ah1 clones indicated that it is actively suppressed by v-ahl. A faint mG-CSFR band was apparent at the permissive temperature on the addition of cycloheximide. The presence of the band may reflect an intrinsically weaker suppressive activity in ts-ab1 mutants or a decreased half-life of the ts-mutant ah1 protein. A densitometric analysis of the time course is shown. mG-CSFR RNA levels are adjusted for 1 8 s loading at each time point and then normalized to mG-CSFR signal at time zero. (C) A representative blot of triplicate experiments examining the effect of IL-3 on mG-CSFR message stability is shown. 32Dc13 cells were removed from IL-3-containing media, rested for 3 hours, and then exposed to 100 U/mL IL-3 for 4 hours followed by exposure to actinomycin D for the time indicated. Twenty-microgram samples of total RNA were blotted and sequentially probed with G-CSFR and 18s.
For 8) , two temperaturesensitive-ab/-transformed 32Dc13 clones at permissive temperature (RK1 and RK3; lanes 9 and 10, respectively) or from untransformed 32Dc13 cells either maintained in 100 U/mL IL-3 (lanes 1 and 2) or rested from IL-3 (lanes 11 through 13). Twenty micrograms of total RNA is loaded in each lane. Hybridizations with mG-CSFR, v-ab/, or actin probes were performed as described in the Materials and Methods.
WEHI-3B D-myelomonocytic leukemic subline, a tetraploid cell line with the morphology of immature macrophages, that does not express detectable mG-CSFR on its surface or respond to G-CSF.36 Whereas the mG-CSFR gene was intact by Southern analysis in WEHI-3B D-(data not shown), neither basal expression of mG-CSFR message nor inducibility by G-CSF was apparent on Northern blotting. Interestingly, these cells did show detectable message in the presence of cycloheximide. The addition of G-CSF led to a further twofold increase in mG-CSFR message when cycloheximide was present (Fig 8) .
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DISCUSSION
This study was undertaken to identify an early marker of myeloid differentiation that could be used to help pinpoint targets of leukemic disruption of differentiation. We have found mG-CSFR message upregulation to be such a marker. We report here our findings that G-CSF specifically upregulated message for its own receptor in normal murine bone marrow and in a cell line model of granulocyte differentiation. This upregulation was rapid, required no new protein synthesis. did not occur in response to IL-3. and did not result from stabilization of mG-CSFR message. The ability of actinomycin D to abrogate mG-CSFR mRNA upregulation by G-CSF suggests that transcriptional activation contributes to increased steady-state mG-CSFR mRNA levels. Upregulation of mG-CSFR mRNA appears to be an immediate early genetic event in myeloid differentiation specific to the G-CSF-transduced differentiation pathway. Also, we found that receptor message could be superinduced by cycloheximide, suggesting that a labile repressor protein may play a part in the normal regulation of mG-CSFR mRNA levels. Having uncovered an early genetic marker of differentiation, we investigated whether its expression was altered by a proliferative stimulus by first examining the effect of IL-3 and then the effect of oncogenic transformation. IL-3 suppressed the ability of G-CSF to upregulate mG-CSFR mRNA expression. mG-CSFR mRNA expression was dysregulated in several myeloid leukemia models; most notably, there was marked suppression of basal mG-CSFR message expression and a block in G-CSF-induced upregulation of mG-CSFR mRNA in cells expressing an active v-ab1 oncogene product. of IL-I receptors on bone marrow cells.*" G-CSF has also been shown to induce expression of GM-CSFRs on 32Dc13 cells: however, this has not been characterized at the RNA level and occurs after a lag of days. disrupted. These cells proliferate rather than differentiate in response to G-CSF. Our data suggest that the differentiation block in NFS60 may be located distal to the control of mG-CSFR gene expression. NFS60 cells constitutively express the evi-I protooncogene, which has been shown to disrupt G-CSF-induced differentiation when expressed in 32Dc13 cells."In this study by Morishita et al," the observation that basal expression of mG-CSFR message was unperturbed in NFS60 cells further supports a downstream site of evi-l action.
The site of differentiation blockage in the WEHI-3B Dleukemic cell line is narrowed somewhat by our data. Earlier findings of undetectable mG-CSFR on the surface of WEHI-3B D-cells had suggested that this was a site of the differentiation block in these cells.42 Although surface expression of mG-CSFR in WEHI D-may be inadequate to propel the complete differentiation program, we found that there was adequate surface receptor for G-CSF to trigger a signal; G-CSF could upregulate mG-CSFR message if added in the presence of cycloheximide (Fig 8) . These findings indicate that the mG-CSFR signal transduction in WEHI 3B D-may be disrupted distal to the surface receptor. The fact that WEHI-3B D+ cells can differentiate in response to G-CSF indicates that mG-CSFR inducibility, which it lacks, is -G C G C 
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itself not required for differentiation. The high constitutive production of mG-CSFR and its message by this subline may obviate such a requirement. Given that G-CSF launches a differentiation cascade in this subline, other coordinately regulated genes could function properly in the differentiation program, even though mG-CSFR upregulation could no longer serve as a marker of their activation.
Further understanding of the mechanism of mG-CSFR gene upregutation and its dysregulation in leukemic cells may be generated from studies of the mG-CSFR promoter. The human G-CSFR promoter sequence has been reported43 and is noted to contain consensus sequences for AP-I, AP-2, and GATA-I binding as well as a myeloperoxidase and elastase promoter sequence homologue. The latter, on its own, is unlikely to modulate G-CSFR upregulation because myeloperoxidase and elastase message increase significantly later than G-CSFR message in the course of G-CSF-driven differentiation. lation of biologically active ribonucleic acid from sources enriched in ribonuclease. 27. Fukunaga R, Ishizaka-Ikeda E, Set0 Y, Nagata S: Expression cloning of a receptor for murine granulocyte colony-stimulating factor. Cell 6 1134 Cell 6 I , 1990 For personal use only. on October 22, 2017. by guest www.bloodjournal.org From
